HRP20211100T1 - Sastav koji sadrži miješani ekstrakt murve i kore poria kokosa za prevenciju, poboljšanje ili liječenje neurodegenerativnih bolesti - Google Patents
Sastav koji sadrži miješani ekstrakt murve i kore poria kokosa za prevenciju, poboljšanje ili liječenje neurodegenerativnih bolesti Download PDFInfo
- Publication number
- HRP20211100T1 HRP20211100T1 HRP20211100TT HRP20211100T HRP20211100T1 HR P20211100 T1 HRP20211100 T1 HR P20211100T1 HR P20211100T T HRP20211100T T HR P20211100TT HR P20211100 T HRP20211100 T HR P20211100T HR P20211100 T1 HRP20211100 T1 HR P20211100T1
- Authority
- HR
- Croatia
- Prior art keywords
- mulberry
- disease
- poria cocos
- use according
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 12
- 235000008708 Morus alba Nutrition 0.000 title claims 11
- 240000000249 Morus alba Species 0.000 title claims 11
- 244000197580 Poria cocos Species 0.000 title claims 11
- 235000008599 Poria cocos Nutrition 0.000 title claims 11
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- 208000012902 Nervous system disease Diseases 0.000 claims 4
- 208000025966 Neurological disease Diseases 0.000 claims 4
- 230000003412 degenerative effect Effects 0.000 claims 4
- 230000000750 progressive effect Effects 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 206010003591 Ataxia Diseases 0.000 claims 2
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 claims 2
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 claims 2
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 claims 2
- 206010012289 Dementia Diseases 0.000 claims 2
- 208000023105 Huntington disease Diseases 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 210000002569 neuron Anatomy 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Claims (14)
1. Farmaceutski sastav za korištenje u prevenciji ili liječenju degenerativne neurološke bolesti, koji sadrži miješani ekstrakt murve i Poria cocos kore kao aktivni sastojak.
2. Farmaceutski sastav za korištenje u skladu sa zahtjevom 1, naznačen time što je degenerativna neurološka bolest odabrana iz skupine koja se sastoji od Alzheimerove bolesti, Creutzfeldt – Jakobove bolesti, Huntingtonove bolesti, multiple skleroze, Guilin – Barreovog sindroma, Parkinsonove bolesti, Lou Gehrigove bolesti, progresivne demencije uzrokovane postupnim odumiranjem neurona, i progresivne ataksije.
3. Farmaceutski sastav za korištenje u skladu sa zahtjevom 1, naznačen time što se miješani ekstrakt murve i Poria cocos kore ekstrahira s vodom, manjim alkoholom s 1 do 4 atoma ugljika, ili mješavinom istih.
4. Farmaceutski sastav za korištenje u skladu sa zahtjevom 1, naznačen time što se miješani ekstrakt murve i Poria cocos kore ekstrahira s 60 do 80 (volumen/volumen)% etanola.
5. Farmaceutski sastav za korištenje u skladu sa zahtjevom 1, naznačen time što je omjer težine murve i Poria cocos kore 4 do 7 : 1.
6. Farmaceutski sastav za korištenje u skladu sa zahtjevom 1, naznačen time što je omjer težine murve i Poria cocos kore 5 : 1.
7. Sastav za korištenje u prevenciji ili poboljšanju degenerativne neurološke bolesti koji sadrži miješani ekstrakt murve i Poria cocos kore kao aktivni sastojak.
8. Sastav za korištenje u skladu sa zahtjevom 7, naznačen time što je degenerativna neurološka bolest odabrana iz skupine koja se sastoji od Alzheimerove bolesti, Creutzfeldt – Jakobove bolesti, Huntingtonove bolesti, multiple skleroze, Guilin – Barre sindroma, Parkinsonove bolesti, Lou Gehrigove bolesti, progresivne demencije uzrokovane postupnim odumiranjem neurona, i progresivne ataksije.
9. Sastav za korištenje u skladu sa zahtjevom 7, naznačen time što se miješani ekstrakt murve i Poria cocos kore ekstrahira s vodom, manjim alkoholom s 1 do 4 atoma ugljika, ili mješavinom istih.
10. Sastav za korištenje u skladu sa zahtjevom 7, naznačen time što se miješani ekstrakt murve i Poria cocos kore ekstrahira s 60 do 80 (volumen/volumen)% etanola.
11. Sastav za korištenje u skladu sa zahtjevom 7, naznačen time što je omjer težine murve i Poria cocos kore 4 do 7 : 1.
12. Sastav za korištenje u skladu sa zahtjevom 7, naznačen time što je omjer težine murve i Poria cocos kore 5 : 1.
13. Sastav za korištenje u skladu s bilo kojim od zahtjeva 7 do 12, naznačen time što je sastav zdravstveno funkcionalna hrana ili zdravstveno funkcionalno piće.
14. Farmaceutski sastav za korištenje u skladu s bilo kojim od zahtjeva 1 do 6 ili sastav za korištenje prema bilo kojem od zahtjeva 7 do 13, koji se primjenjuje oralno, intrarektalno, intravenozno, intramuskularno, potkožno, intrauterino duralno, ili intracerebralno.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020140184854A KR101671437B1 (ko) | 2014-12-19 | 2014-12-19 | 상심자 및 복령피 혼합 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물 |
| PCT/KR2015/013134 WO2016099055A2 (ko) | 2014-12-19 | 2015-12-03 | 상심자 및 복령피 혼합 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물 |
| EP15870222.5A EP3235503B1 (en) | 2014-12-19 | 2015-12-03 | Composition containing mixed extract of mulberry and poria cocos bark for preventing, improving or treating neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20211100T1 true HRP20211100T1 (hr) | 2021-10-15 |
Family
ID=56127795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20211100TT HRP20211100T1 (hr) | 2014-12-19 | 2021-07-09 | Sastav koji sadrži miješani ekstrakt murve i kore poria kokosa za prevenciju, poboljšanje ili liječenje neurodegenerativnih bolesti |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US10588927B2 (hr) |
| EP (2) | EP3235503B1 (hr) |
| JP (3) | JP6546281B2 (hr) |
| KR (1) | KR101671437B1 (hr) |
| CN (2) | CN107106624B (hr) |
| BR (1) | BR112017012906A2 (hr) |
| CY (1) | CY1124857T1 (hr) |
| DK (1) | DK3235503T3 (hr) |
| ES (1) | ES2868774T3 (hr) |
| HR (1) | HRP20211100T1 (hr) |
| HU (1) | HUE055024T2 (hr) |
| LT (1) | LT3235503T (hr) |
| PL (1) | PL3235503T3 (hr) |
| PT (1) | PT3235503T (hr) |
| RS (1) | RS62093B1 (hr) |
| RU (1) | RU2679654C2 (hr) |
| SI (1) | SI3235503T1 (hr) |
| WO (1) | WO2016099055A2 (hr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101698163B1 (ko) | 2014-12-19 | 2017-01-19 | 동아에스티 주식회사 | 복령피 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물 |
| KR101671437B1 (ko) * | 2014-12-19 | 2016-11-01 | 동아에스티 주식회사 | 상심자 및 복령피 혼합 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물 |
| KR102295786B1 (ko) * | 2016-09-06 | 2021-09-01 | 신파 티엔리 파머슈티컬 컴퍼니 리미티드 (항저우) | 스킨케어 및/또는 상처치유 촉진에 있어서 복령 추출물 및 이의 활성 성분의 용도 |
| CN108522908A (zh) * | 2018-04-03 | 2018-09-14 | 苏州市天灵中药饮片有限公司 | 一种改善记忆力口服液的制备方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997029764A1 (fr) | 1996-02-15 | 1997-08-21 | Daiichi Pharmaceutical Co., Ltd. | Activateurs cerebraux |
| JPH10330266A (ja) * | 1997-06-02 | 1998-12-15 | Kotarou Kanpo Seiyaku Kk | インスリン作用増強活性組成物 |
| JPH11255662A (ja) * | 1998-03-09 | 1999-09-21 | Kamiyama Fumio | 糖吸収抑制剤 |
| KR100526628B1 (ko) * | 2003-03-21 | 2005-11-08 | 주식회사 에스티씨나라 | 모노아민산화효소 저해활성을 갖는 상심자 추출물을함유한 조성물 |
| KR20050092292A (ko) | 2004-03-15 | 2005-09-21 | 주식회사 크라우젠 | 기억력 증강 효과가 있는 생약재 조성물 |
| KR100779179B1 (ko) | 2006-05-19 | 2007-11-28 | 충북대학교 산학협력단 | 토복령의 메탄올 추출물을 함유하는 뇌신경 보호 또는퇴행성뇌질환 예방 또는 치료제 |
| KR100847343B1 (ko) * | 2006-12-08 | 2008-07-21 | 경희대학교 산학협력단 | 생약복합재 추출물을 함유하는 골길이 성장 촉진용 조성물 |
| CN101152554A (zh) * | 2007-09-24 | 2008-04-02 | 徐大洋 | 治疗荨麻疹既泄热消疹的中药 |
| KR20090071704A (ko) | 2007-12-28 | 2009-07-02 | 퓨리메드 주식회사 | 치매 예방 및 치료용 조성물 |
| US20100285002A1 (en) * | 2008-01-04 | 2010-11-11 | Immune Disease Institute, Inc. | Treatment or prevention of inflammation by targeting cyclin d1 |
| KR101072662B1 (ko) * | 2008-12-18 | 2011-10-11 | 대구한의대학교산학협력단 | 복신 건조분말 또는 그 추출물을 유효성분으로 함유하는건망증 및 기억력 장애 관련 질환의 예방 및 치료용 조성물 |
| KR101064258B1 (ko) | 2008-12-29 | 2011-09-14 | 한국과학기술연구원 | 벤조아릴우레이도 화합물, 및 이를 함유하는 퇴행성 뇌질환예방 또는 치료용 조성물 |
| KR20100083632A (ko) | 2009-01-14 | 2010-07-22 | 울산대학교 산학협력단 | 표적 단백질 분해효소 감응형 항암제 전구체 |
| KR20110070514A (ko) | 2009-12-18 | 2011-06-24 | 한국전자통신연구원 | 헤드 마운트 디스플레이 장치 및 3차원 그래픽 사용자 인터페이스 상에서 3차원 공간 터치를 제어하는 방법 |
| KR20110119983A (ko) * | 2010-04-28 | 2011-11-03 | 순천대학교 산학협력단 | 뽕나무 열매 추출물을 함유하는 아세틸콜린에스테라제 억제용 조성물 |
| CN102133351B (zh) * | 2011-03-04 | 2012-05-09 | 费萍 | 一种治疗阿尔茨海默病的药物组合物及其制备方法 |
| CN102133242B (zh) | 2011-03-07 | 2013-12-11 | 北京中医药大学 | 一种茯苓提取物及其制备方法 |
| JP6108452B2 (ja) * | 2012-04-12 | 2017-04-05 | クラシエ製薬株式会社 | 細胞死抑制組成物 |
| KR101251866B1 (ko) * | 2012-07-12 | 2013-04-10 | 순천대학교 산학협력단 | 뽕나무 열매 추출물을 함유하는 아세틸콜린에스테라제 억제용 조성물 |
| WO2014088200A1 (ko) * | 2012-12-06 | 2014-06-12 | 한국식품연구원 | 복령피 추출물, 백미 추출물 또는 남성 추출물을 유효성분으로 포함하는 면역 질환의 예방, 개선 또는 치료용 조성물 |
| KR101577392B1 (ko) | 2012-12-06 | 2015-12-17 | 한국식품연구원 | 복령피 추출물을 유효성분으로 포함하는 Ｔｈ1-매개 면역 질환 또는 Ｔｈ2-매개 면역 질환의 예방, 개선 또는 치료용 조성물 |
| CN103393809B (zh) | 2013-07-24 | 2015-01-07 | 张立东 | 治疗帕金森的药物 |
| CN104013891A (zh) | 2014-05-28 | 2014-09-03 | 高益槐 | 一种益智健脑的复方制剂及其制备方法 |
| KR101671437B1 (ko) | 2014-12-19 | 2016-11-01 | 동아에스티 주식회사 | 상심자 및 복령피 혼합 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물 |
-
2014
- 2014-12-19 KR KR1020140184854A patent/KR101671437B1/ko active IP Right Grant
-
2015
- 2015-12-03 HU HUE15870222A patent/HUE055024T2/hu unknown
- 2015-12-03 ES ES15870222T patent/ES2868774T3/es active Active
- 2015-12-03 DK DK15870222.5T patent/DK3235503T3/da active
- 2015-12-03 RU RU2017123242A patent/RU2679654C2/ru active
- 2015-12-03 CN CN201580069209.6A patent/CN107106624B/zh active Active
- 2015-12-03 WO PCT/KR2015/013134 patent/WO2016099055A2/ko active Application Filing
- 2015-12-03 EP EP15870222.5A patent/EP3235503B1/en active Active
- 2015-12-03 RS RS20210850A patent/RS62093B1/sr unknown
- 2015-12-03 LT LTEP15870222.5T patent/LT3235503T/lt unknown
- 2015-12-03 CN CN202110519226.2A patent/CN113384619A/zh active Pending
- 2015-12-03 US US15/535,489 patent/US10588927B2/en active Active
- 2015-12-03 JP JP2017531902A patent/JP6546281B2/ja active Active
- 2015-12-03 PT PT158702225T patent/PT3235503T/pt unknown
- 2015-12-03 EP EP21162199.0A patent/EP3895721A1/en not_active Withdrawn
- 2015-12-03 BR BR112017012906-0A patent/BR112017012906A2/pt not_active Application Discontinuation
- 2015-12-03 PL PL15870222T patent/PL3235503T3/pl unknown
- 2015-12-03 SI SI201531630T patent/SI3235503T1/sl unknown
-
2019
- 2019-01-18 JP JP2019006878A patent/JP6773821B2/ja active Active
-
2020
- 2020-03-16 US US16/820,639 patent/US10946053B2/en active Active
- 2020-10-01 JP JP2020166716A patent/JP2021006558A/ja active Pending
-
2021
- 2021-02-08 US US17/169,905 patent/US20210283206A1/en not_active Abandoned
- 2021-07-09 HR HRP20211100TT patent/HRP20211100T1/hr unknown
- 2021-07-13 CY CY20211100625T patent/CY1124857T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20211100T1 (hr) | Sastav koji sadrži miješani ekstrakt murve i kore poria kokosa za prevenciju, poboljšanje ili liječenje neurodegenerativnih bolesti | |
| MX2018002157A (es) | Conjugados de aldehido y usos de los mismos. | |
| MY196319A (en) | Polycyclic TLR7/8 Antagonists and use Thereof in the Treatment of Immune Disorders | |
| MX2019012878A (es) | Terapias para el tratamiento de enfermedades asociadas con la toxicidad del aldehido. | |
| MX2016011038A (es) | Compuestos para el tratamiento de trastornos mediados por complemento. | |
| PH12016501307B1 (en) | Compounds | |
| MX2018002155A (es) | Compuestos deuterados y usos de los mismos. | |
| MX2019001722A (es) | Compuestos de captura de aldehido y usos de los mismos. | |
| MX2017006483A (es) | Compuestos aminopirazina con propiedades antagonistas a2a. | |
| WO2013158680A3 (en) | Compositions and methods comprising celecoxib or related compounds and dextromethorphan | |
| MX370785B (es) | Composiciones farmacéuticas que contienen fumarato de dimetilo. | |
| MX2020012978A (es) | Sales de sepiapterina farmacéuticamente aceptables. | |
| EA033113B1 (ru) | Способы лечения аутоиммунных, респираторных и воспалительных расстройств ингаляцией n-оксида рофлумиласта | |
| EA201991387A1 (ru) | ТРИЦИКЛИЧЕСКИЕ ЕНОНЫ - ПРОИЗВОДНЫЕ ПИРИМИДИНА ДЛЯ ИНГИБИРОВАНИЯ ROR-γ И ДРУГИХ ПРИМЕНЕНИЙ | |
| MX2021005207A (es) | Formulaciones de 2-(terc-butilamino)-4-((1r,3r,4r)-3-hidroxi-4-met ilciclohexilamino)-pirimidina-5-carboxamida. | |
| MX370141B (es) | Profármacos que comprenden un conjugado de ácido hialurónico enlazador agonista dual de glp-1/glucagón. | |
| IN2014DN07885A (hr) | ||
| EA201692388A1 (ru) | Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы | |
| AR101674A1 (es) | Uso de un compuesto tricíclico que contiene nitrógeno | |
| AR099385A1 (es) | Formulaciones de 3-(5-amino-2-metil-4-oxo-4h-quinazolin-3-il)-piperidina-2,6-diona | |
| CU20130168A7 (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib | |
| PH12019500822A1 (en) | Crystalline forms of eravacycline | |
| BR112019004236A2 (pt) | compostos para tratar doenças associadas a uma disfunção mitocondrial | |
| BR112017021583A2 (pt) | métodos para o tratamento de transtornos inflamatórios | |
| NZ718185A (en) | Pharmaceutical composition containing verbenone derivative for treating or preventing neurodegenerative disease |